Table 4. Responses to survey-comprehension questions.
| Statistic or Category | All Respondents (N = 323) | |
|---|---|---|
| How many people achieved complete response after taking Treatment A? | ||
| 5 out of 100 (5%) | 6 (1.86%) | |
| 10 out of 100 (10%) [CORRECT ANSWER] | 199 (61.6%) | |
| 20 out of 100 (20%) | 86 (26.6%) | |
| 80 out of 100 (80%) | 30 (9.3%) | |
| Don’t know / not sure | 2 (0.6%) | |
| What kind of treatment is Treatment B? | ||
| Oral | 91 (28.2%) | |
| Injection | 73 (22.6%) | |
| Intravenous [CORRECT ANSWER] | 152 (47.1%) | |
| Don’t know / not sure | 7 (2.2%) | |
| How long is Treatment B expected to keep the cancer from getting worse? | ||
| 12 months | 44 (13.6%) | |
| 18 months | 68 (21.1%) | |
| 24 months [CORRECT ANSWER] | 205 (63.5%) | |
| 48 months | 5 (1.6%) | |
| Don’t know / not sure | 1 (0.3%) | |
| Which treatment is taken as an injection? | ||
| Treatment A [CORRECT ANSWER] | 233 (72.1%) | |
| Treatment B | 87 (26.9%) | |
| Don’t know / not sure | 3 (0.9%) | |
| Based on what you saw in the video, select True, False or Don’t Know/Not sure for each statement: | ||
| CAR-T therapy requires taking the patient’s own T cells and changing them to start attacking cancer cells in the body | True [CORRECT ANSWER] | 292 (90.4%) |
| False | 27 (8.4%) | |
| Don’t know | 4 (1.2%) | |
| CAR-T therapy requires using chemotherapy to make space for new T cells | True [CORRECT ANSWER] | 244 (75.5%) |
| False | 65 (20.1%) | |
| Don’t know | 14 (4.3%) | |
| Based on what you saw in the video, select True, False or Don’t know/Not sure for each statement: | ||
| BiTE® therapy modifies the patient’s T cell to attack cancer cells in the body | True | 252 (78.0%) |
| False [CORRECT ANSWER] | 64 (19.8%) | |
| Don’t know | 7 (2.2%) | |
| BiTE® therapy is taken only once | True | 160 (49.5%) |
| False [CORRECT ANSWER] | 142 (44.0%) | |
| Don’t know | 21 (6.5%) | |
| Based on what you saw in the video, select True, False or Don’t know/Not sure for each statement: | ||
| ADC therapy uses the patient’s T cells to fight multiple myeloma | True | 245 (75.9%) |
| False [CORRECT ANSWER] | 69 (21.4%) | |
| Don’t know | 9 (2.8%) | |
| ADC therapy delivers medicine directly to cancer cells in your body | True [CORRECT ANSWER] | 258 (79.9%) |
| False | 51 (15.8%) | |
| Don’t know | 14 (4.3%) |
CAR-T = Chimeric Antigen Receptor; BiTE® = Bispecific T-Cell Engager; ADC = Anti-Drug Conjugate.
Note 1: Percentages do not include missing responses in the denominator